Thursday, May 23, 2024 10:01:38 AM
I’m quite certain we’ll have big news soon.
The impact of the news on the stock price may change my opinion.
If I’m wrong and they don’t make announcement(s), it’s a NO for sure.
Here what ChapGPT says about the proxy
“In the United States, public companies are required to distribute proxy materials to shareholders ahead of the annual shareholder meeting (ASM). According to the rules set by the Securities and Exchange Commission (SEC), companies must send proxy statements at least 40 calendar days before the meeting date if the proxy materials are being delivered electronically (under the Notice and Access model). This model allows companies to provide shareholders with a notice of availability of the proxy materials online, rather than sending the full set of materials by mail immediately.
If a company chooses not to use the Notice and Access model and instead sends the full set of proxy materials by mail, they typically need to do so at least 30 days before the meeting.
These timelines ensure that shareholders have adequate time to review the materials and make informed voting decisions on the matters to be addressed at the ASM.”
The impact of the news on the stock price may change my opinion.
If I’m wrong and they don’t make announcement(s), it’s a NO for sure.
Here what ChapGPT says about the proxy
“In the United States, public companies are required to distribute proxy materials to shareholders ahead of the annual shareholder meeting (ASM). According to the rules set by the Securities and Exchange Commission (SEC), companies must send proxy statements at least 40 calendar days before the meeting date if the proxy materials are being delivered electronically (under the Notice and Access model). This model allows companies to provide shareholders with a notice of availability of the proxy materials online, rather than sending the full set of materials by mail immediately.
If a company chooses not to use the Notice and Access model and instead sends the full set of proxy materials by mail, they typically need to do so at least 30 days before the meeting.
These timelines ensure that shareholders have adequate time to review the materials and make informed voting decisions on the matters to be addressed at the ASM.”
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
